[{"data": {"name": "An Argument for the Universal Prophylaxis of Hepatitis B Infection in Patients Receiving Rituximab: A 7-Year Institutional Experience of Hepatitis Screening", "@type": "ScholarlyArticle", "genre": "journal-article", "author": [{"name": "C. Leung", "@type": "Person"}, {"name": "E. Tsoi", "@type": "Person"}, {"name": "G. Burns", "@type": "Person"}, {"name": "W. Sievert", "@type": "Person"}], "@context": "http://schema.org/", "encoding": [{"@type": "MediaObject", "contentUrl": "http://theoncologist.alphamedpress.org/content/16/5/579.full.pdf", "encodingFormat": "application/pdf"}], "publisher": {"name": "Alphamed Press", "@type": "Organization"}, "identifier": [{"@type": "PropertyValue", "value": "10.1634/theoncologist.2010-0182", "propertyID": "DOI"}, {"@type": "PropertyValue", "value": "CChUc7foaSM66-CTcF5AdLHNaut-CDgsszbEeKvQu-CR8pMxzP8Wajv", "propertyID": "ISCC"}], "datePublished": "2011-04-04"}, "schema": "schema.org", "mediatype": "application/ld+json"}]